Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 17 EP applications Beate Binsack has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 29, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12153341

Factor XII inhibitors for the treatment of neurological inflammatory disorders

IPC classification:
A61P 37/00, A61P 25/00, A61K 47/48, A61K 39/395, A61K 38/57, A61K 38/55, A61K 38/48, A61K 38/06
Applicant:
CSL Ltd.
Applicant:
University of Münster (Westfälische Wilhelms-Universität Münster)
Applicant:
CSL Behring GmbH
Applicant:
Julius-Maximilians-University of Wuerzburg (Universität Würzburg)
Agent:
Beate Binsack, CSL Behring GmbH
Status:
APPLICATION REFUSED
EP12707782

FACTOR XII INHIBITORS FOR THE ADMINISTRATION WITH MEDICAL PROCEDURES COMPRISING CONTACT WITH ARTIFICIAL SURFACES

IPC classification:
A61K 39/395, A61K 38/57, A61K 38/55, C07K 16/36, A61P 9/10
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
The patent has been granted
EP12707624

FACTOR XII INHIBITORS FOR THE TREATMENT OF SILENT BRAIN ISCHEMIA AND ISCHEMIA OF OTHER ORGANS

IPC classification:
A61K 49/00, A61K 39/395, A61K 38/57, A61K 38/55, G01N 33/50, C07K 16/36, A61P 9/10
Applicant:
Massachusetts General Hospital
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
PATENT GRANTED
EP12719993

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS

IPC classification:
A61K 38/57, A61K 35/16, A61K 31/727, A61P 11/08, A61P 9/12, A61P 9/06, A61P 7/02, A61P 1/00
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
The patent has been granted
EP12808401

USE OF C1-INHIBITOR FOR THE TREATMENT OF SECONDARY EDEMA OF THE CENTRAL NERVOUS SYSTEM

IPC classification:
A61K 38/57, A61P 9/10, A61P 7/10
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13701651

FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS

IPC classification:
A61K 47/48, A61K 39/395, A61K 38/57, A61K 38/55, A61K 38/48, A61K 38/06, C07K 14/00, A61P 37/00, A61P 25/00
Applicant:
CSL Ltd.
Applicant:
Julius-Maximilians-University of Wuerzburg (Universität Würzburg)
Applicant:
University of Münster (Westfälische Wilhelms-Universität Münster)
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP12761739

COMBINATION THERAPY USING IMMUNOGLOBULIN AND C1-INHIBITOR

IPC classification:
A61K 39/395, A61K 38/55, A61P 9/10
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13823892

A METHOD FOR POLISHING ALBUMIN

IPC classification:
A61K 38/38, C07K 14/76, C07K 1/16
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
The patent has been granted
EP13777203

A METHOD OF PURIFYING PROTEINS

IPC classification:
C07K 14/79, C07K 14/47, C07K 1/36, C07K 1/30, C07K 1/16, C07K 1/14
Applicant:
CSL Behring AG
Applicant:
CSL Behring LLC
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP13851610

RECONSTITUTED HDL FORMULATION

IPC classification:
A61K 38/17, A61P 3/06
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13861334

A METHOD OF PURIFYING THERAPEUTIC PROTEINS

IPC classification:
A61K 38/37, A61K 38/36, C07K 14/755, C07K 14/75, C07K 1/20, C07K 1/18
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14707379

THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM

IPC classification:
A61P 43/00, A61K 38/57
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
PATENT GRANTED
EP14708308

TREATMENT AND PREVENTION OF REMOTE ISCHEMIA-REPERFUSION INJURY

IPC classification:
A61P 7/02, A61K 38/57, A61K 39/395
Applicant:
CSL Behring GmbH
Applicant:
University of Bern (Universität Bern)
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP14808213

PROCESS FOR PREPARING APOLIPOPROTEIN A-I (APO A-I)

IPC classification:
A61P 3/06, A61K 31/688, A61K 31/685, A61K 38/17, C07K 1/36, C07K 1/34, C07K 1/30, C07K 1/14, C07K 14/775
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14739078

COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR

IPC classification:
A61K 31/727, A61K 31/60, A61K 31/519, A61K 31/4365, A61K 47/48, A61K 39/395, A61K 38/57, A61K 45/06
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14833626

CONTAMINANT REMOVAL METHOD

IPC classification:
A61K 38/16, C07K 1/36, C07K 1/34, C07K 14/775
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP16705521

PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR

IPC classification:
A61K 38/00, A61K 9/00
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
Request for examination was made

Please Sign in to use this feature